1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity

Brain Research

Volumn 1051, Issue 1-2, 2005, Pages 145-154

  Lorenc Koci, Elzbieta ^a   Gołembiowska, Krystyna ^a   Wardas, Jadwiga ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1,2,3,4 tetrahydroisoquinoline; Malonate toxicity; Neuroprotection from malonate toxicity

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; DOPAMINE TRANSPORTER; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; MALONIC ACID; NITRIC OXIDE; TETRAHYDROISOQUINOLINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FOREBRAIN; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE; ENERGY METABOLISM; MALE; MALONATES; MEDIAL FOREBRAIN BUNDLE; NEOSTRIATUM; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE; TETRAHYDROISOQUINOLINES;

EID: 22144462146     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.06.007     Document Type: Article

References (95)

1. D.S. Albers, S.W. Weiss, M.J. Iadarola, and D.G. Standaert Immunohistochemical localization of N-methyl-d-aspartate and alpa-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat Neuroscience 89 1999 209 220
2. L. Antkiewicz-Michaluk, I. Romańska, I. Papla, J. Michaluk, M. Baklarz, J. Vetulani, A. Krygowska-Wajs, and A. Szczudlik Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain Neuroscience 96 2000 59 64
3. M.F. Beal, E. Brouillet, B. Jenkins, R. Henshaw, B. Rosen, and B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1150
4. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J. Neurochem. 73 1999 1127 1137
5. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations J. Neurol. Sci. 20 1973 415 455
6. P. Calabresi, P. Gubellini, B. Picconi, D. Centonze, A. Pisani, P. Bonsi, P. Greengard, R.A. Hipskind, E. Borrelli, and G. Bernardi Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine J. Neurosci. 21 2001 5110 5120
7. C.C. Chiueh Neuroprotective properties of nitric oxide Ann. N. Y. Acad. Sci. 890 1999 301 311
8. C.C. Chiueh, and P. Rauhala The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications Free Radical Res. 31 1999 641 650
9. C.C. Chiueh, G. Krishna, P. Tulsi P, T. Obata, K. Lang, S.-J. Huang, and D.J. Murphy Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus Free Radical Biol. Med. 13 1992 581 583
10. N.H.P. Cnubben, I.M.C.M. Rietjens, H. Wortelboer, J. van Zanden, and P.J. van Bladeren The interplay of glutathione-related processes in antioxidant defense Environ. Toxicol. Pharmacol. 10 2001 141 152
11. G. Cohen, and N. Kesler Monoamine oxidase and mitochondrial respiration J. Neurochem. 73 1999 2310 2315
12. 2 production and S-thiolation Free Radical Biol. Med. 27 1999 623 635
13. R. Dringen, O. Kranich, and B. Hamprecht The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture Neurchem. Res. 6 1997 727 733
14. R. Dringen, B. Pfeiffer, and B. Hamprecht Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione J. Neurosci. 19 1999 562 569
15. R. Drozdz, C. Parmentier, H. Hachad, P. Leroy, G. Siest, and M. Wellman γ-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system Free Radical Biol. Med. 25 1998 786 792
16. J.L. Eberling, K.S. Bankiewicz, P. Pivirotto, J. Bringas, K. Chen, D.P. Nowotnik, J.P. Steiner, T.F. Budinger, and W.J. Jagust Dopamine transporter loss and clinical changes in MPTP-lesioned primates Brain Res. 832 1999 184 187
17. J. Ehrhart, and G.D. Zeevalk Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures J. Neurochem. 86 2003 1487 1497
18. B. Ferger, O. Eberhardt, P. Teismann, C. de Groote, and J.B. Schulz Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation J. Neurochem. 73 1999 1329 1332
19. M.R. Gluck, and G.D. Zeevalk Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases J. Neurochem. 91 2004 788 795
20. 2 and hydroxyl radicals but not glutathione-protein-mixed disulfides J. Neurochem. 82 2002 66 74
21. 2A receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats Neuropharmacology 47 2004 414 426
22. J.G. Greene, and J.T. Greenamyre Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate J. Neurochem. 64 1995 430 436
23. J.G. Greene, R.H.P. Porter, R.V. Eller, and J.T. Greenamyre Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum J. Neurochem. 61 1993 1151 1154
24. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
25. N. Guo, and C. Shaw Characterization and localization of glutathione binding sites on cultured astrocytes Mol. Brain Res. 15 1992 207 215
26. N. Guo, C. McIntosh, and C. Shaw Glutathione: new candidate neuropeptide in the central nervous system Neuroscience 51 1992 835 842
27. O. Hornykiewicz Biochemical aspects of Parkinson's disease Neurology 51 Suppl. 2 1998 S2 S9
28. 2 receptors in the mouse striatum J. Neurochem. 79 2001 868 876
29. R. Janáky, K. Ogita, B.A. Pasqualotto, J.S. Bains, S.S. Oja, Y. Yoneda, and C.A. Shaw Glutathione and signal transduction in the mammalian CNS J. Neurochem. 73 1999 889 902
30. R. Janáky, C.A. Shaw, V. Varga, A. Hermann, R. Dohovics, P. Saransaari, and S.S. Oja Specific glutathione binding sites in pig cerebral cortical synaptic membranes Neuroscience 95 2000 617 624
31. T.-C. Ju, Y.-T. Yang, and D.-I. Yang Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat Neurosci. Lett. 362 2004 226 231
32. M.J. Kaufman, and B.K. Madras Severe depletion of cocaine recognition sites associated with the depletion transporter in Parkinson's-diseased striatum Synapse 9 1991 43 49
33. K. Kikuchi, Y. Nagatsu, Y. Makino, T. Mashino, S. Ohta, and M. Hirobe Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4- tetrahydroisoquinoline Drug Metab. Dispos. 19 1990 257 262
34. M. Kohno, S. Ohta, and M. Hirobe Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain Biochem. Biophys. Res. Commun. 140 1986 448 454
35. J.R.F. König, and R.A. Klippel The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem 1963 Williams and Wilkins Baltimore, MD
36. E. Lorenc-Koci, M. Śmiałowska, L. Antkiewicz-Michaluk, K. Gołembiowska, K. Bajkowska, and S. Wolfarth Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats Neuroscience 95 2000 1049 1059
37. E. Lorenc-Koci, M. Sokołowska, and L. Włodek Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of γ-glutamyl transpeptidase in dopaminergic structures of rat brain Neuroscience 108 2001 413 420
38. 3H]GBR 12,935 to dopamine transporter in the nigrostriatal dopaminergic system Brain Res. 1009 2004 67 81
39. E. Lorenc-Koci, J. Wójcikowski, M. Kot, A. Haduch, J. Boksa, and W.A. Daniel Disposition of 1,2,3,4-tetrahydroisoquinoline in the brain of male Wistar and Dark Agouti rats Brain Res. 996 2004 168 179
40. E. Lorenc-Koci, M. Sokołowska, I. Kwiecień, and L. Włodek Treatment with 1,2,3,4-tetrahydroisoquinoline affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of γ-glutamyl transpeptidase in dopaminergic structures of rat brain Brain Res. 2005 10.1016/j.brainres.2005.04.039
41. K. Magyar, B. Szende, J. Lengyel, J. Tarczali, and I. Szatmary The neuroprotective and neuronal rescue effects of (-)-deprenyl J. Neural Transm., Suppl. 52 1998 109 123
42. Y. Makino, S. Ohta, O. Tachikawa, and M. Hirobe Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease Life Sci. 43 1988 373 378
43. W.F. Maragos, K.L. Young, C.S. Altman, C.B. Pocernich, J. Drake, D.A. Butterfield, I. Seif, D.P. Holschneider, K. Chen, and J.C. Shih Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice Neurochem. Res. 29 2004 741 746
44. B.A. McLaughlin, D. Nelson, M. Erecińska, and M.F. Chesselet Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor J. Neurochem. 70 1998 2406 2415
45. K.St.P. McNaught, C. Altomare, S. Cellamare, A. Carotti, U. Thull, P.-A. Carrupt, B. Testa, P. Jenner, and C.D. Marsden Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine NeuroReport 6 1995 1105 1108
46. K.St.P. McNaught, U. Thull, P.-A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, and C.D. Marsden Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,4- tetrahydropyridine Biochem. Pharmacol. 50 1995 1903 1911
47. 3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Biochem. Pharmacol. 52 1996 29 34
48. K.St.P. McNaught, U. Thull, P.-A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, and C.D. Marsden Effect of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on mitochondrial respiration Biochem. Pharmacol. 51 1996 1503 1511
49. K.St.P. McNaught, P.-A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, and C.D. Marsden Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease Biochem. Pharmacol. 56 1998 921 933
50. 3H-GBR 12935 J. Neural Transm.: Gen. Sect. 87 1992 1 14
51. C.A. Messam, J.G. Greene, J.T. Greenamyre, and M.B. Robinson Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801 Brain Res. 684 1995 221 224
52. J. Miller, J. Selhub, and J. Joseph Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin Free Radical Biol. Med. 21 1996 241 249
53. K. Mizukawa, E.G. McGeer, and P.L. McGeer Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls Mol. Chem. Neuropathol. 18 1993 133 144
54. Y. Mizuno, S. Matuda, H. Yoshino, H. Mori, N. Hattori, and S. Ikebe An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease Ann. Neurol. 35 1994 204 210
55. L.Y. Moy, G.D. Zeevalk, and P.K. Sonsalla Role for dopamine in malonate-induced damage in vivo in striatum an in vitro in mesencephalic cultures J. Neurochem. 74 2000 1656 1665
56. T. Nagatsu Isoquinoline neurotoxins in the brain and Parkinson's disease Neurosci. Res. 29 1997 99 111
57. T. Niwa, N. Takeda, N. Kaneda, Y. Hashizume, and T. Nagatsu Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains Biochem. Biophys. Res. Commun. 144 1987 1084 1089
58. T. Niwa, N. Takeda, A. Tatematsu, S. Matsuura, M. Yoshida, and T. Nagatsu Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry J. Chromatogr., Biomed. Appl. 452 1988 85 91
59. T. Niwa, N. Takeda, T. Sasaoka, N. Kaneda, Y. Hashizume, H. Yoshizumi, A. Tatematsu, and T. Nagatsu Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use gas chromatography-mass spectrometry J. Chromatogr., Biomed. Appl. 491 1989 397 403
60. T. Niwa, H. Yoshizumi, A. Tatematsu, S. Matsuura, and T. Nagatsu Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods J. Chromatogr., Biomed. Appl. 493 1989 347 352
61. M. Ogawa, M. Araki, I. Nagatsu, T. Nagatsu, and M. Yoshida The effect of 1,2,3,4-tetrahydroisoquinoline (TIQ) on mesencephalic dopaminergic neurons in C57BL/6J mice: immunohistochemical studies (tyrosine hydroxylase Biog. Amines 6 1989 427 436
62. S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, and M. Hirobe Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease Biomed. Res. 8 1987 453 456
63. T. Oishi, E. Hasegawa, and Y. Murai Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse J. Neural Transm.: Parkinson's Dis. Dement. Sect. 6 1993 45 52
64. S.S. Oja, R. Janáky, V. Varga, and P. Saransaari Modulation of glutamate receptor functions by glutathione Neurochem. Int. 37 2000 299 306
65. A. Paolicchi, S. Dominici, L. Pieri, E. Maellaro, and A. Pompella Glutathione catabolism as a signaling mechanism Biochem. Pharmacol. 64 2002 1027 1035
66. A. Patsenka, and L. Antkiewicz-Michaluk Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds-1,2,3,4- tetrahydro-isoquinoline alkaloids Pol. J. Pharmacol. 56 2004 727 734
67. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press San Diego
68. E. Pileblad, T. Magnusson, and B. Fornstedt Reduction of brain glutathione by l-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum J. Neurochem. 52 1989 978 980
69. H. Rommelspacher, and R. Susilo Tetrahydroisoquinolines and β-carbolines: putative natural substances in plants and mammals Prog. Drug Res. 29 1985 415 459
70. J. Sagara, K. Miura, and S. Bannai Maintenance of neuronal glutathione by glial cells J. Neurochem. 61 1993 1677 1684
71. J. Sagara, K. Miura, and S. Bannai Glutathione efflux from cultured astrocytes J. Neurochem. 66 1996 1876 1881
72. T. Saitoh, Y. Mizuno, T. Nagatsu, and M. Yoshida Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice Neurosci. Lett. 92 1988 321 324
73. A.H. Schapira Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia Biochim. Biophys. Acta 1410 1999 159 170
74. T.A. Seaton, P. Jenner, and C.D. Marsden Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain J. Neural Transm. 103 1996 315 329
75. P.K. Sonsalla, L. Manzino, C.M. Sinton, C.L. Liang, D.C. German, and G.D. Zeevalk Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra Brain Res. 773 1997 223 226
76. P.K. Sonsalla, D.S. Albers, and G.D. Zeevalk Role of glutamate in neurodegeneration of dopamine neurons in several models of parkinsonism Amino Acids 14 1998 69 74
77. K. Sriram, K.S. Pai, M.R. Boyd, and V. Ravindranath Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice Brain Res. 749 1997 44 52
78. A.A. Stark, E. Zeiger, and D.A. Pagano Glutathione metabolism by γ-glutamyl transpeptidase leads to lipids peroxidation: characterization of the system and relevance to hepatocarcinogenesis Carcinogenesis 14 1993 183 189
79. G. Stern Neuroprotection by selegiline and other MAO inhibitors J. Neural Transm., Suppl. 52 1998 99 107
80. A. Storch, S. Ott, Y.-I. Hwang, R. Ortmann, A. Hein, S. Frenzel, K. Matsubara, S. Ohta, H.-U. Wolf, and J. Schwarz Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter Biochem. Pharmacol. 63 2002 909 920
81. C.E. Thomas, D.F. Ohlweiler, A.A. Carr, T.R. Nieduzak, D.A. Hay, G. Adams, R. Vaz, and R.C. Bernotas Characterization of the radical trapping activity of a novel series of cyclic nitrone spin traps J. Biol. Chem. 271 1996 3097 3104
82. S. Toffa, G.M. Kunikowska, B.-Y. Zeng, P. Jenner, and C.D. Marsden Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration J. Neural Transm. 104 1997 67 75
83. X.F. Wang, and M.S. Cyander Astrocytes provide cysteine to neurones by releasing glutathione J. Neurochem. 74 2000 1434 1442
84. J.M. Wilson, A.I. Levey, A. Rajput, L. Ang, M. Guttman, K. Shannak, H.B. Niznik, O. Hornykiewicz, C. Pifl, and S.J. Kish Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease Neurology 47 1996 718 726
85. U. Wüllner, P.-A. Löschmann, J.B. Schulz, A. Schmid, R. Dringen, F. Eblen, L. Turski, and T. Klockgether Glutathione depletion potentiates MPTP toxicity in nigral dopaminergic neurones NeuroReport 7 1996 921 923
86. T. Yamakawa, and S. Ohta Isolation of 1-methyl-1,2,3,4- tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme Biochem. Biophys. Res. Commun. 236 1997 676 681
87. T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, and S. Ohta Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neurosci. Lett. 276 1999 68 70
88. V.W. Yong, T.L. Perry, and A.A. Krisman Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pre-treatment Neurosci. Lett. 63 1986 56 60
89. L. Zangerle, M. Cuenod, K.H. Winterhalter, and K.Q. Do Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices J. Neurochem. 59 1992 181 189
90. M.E. Zarranz de Ysern, and L.A. Ordonez Tetrahydroisoquinolins: a review Prog. Neuro-Psychopharmacol. 5 1981 343 355
91. G.D. Zeevalk, E. Derr-Yellin, and W.J. Nicklas Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade J. Pharmacol. Exp. Ther. 275 1995 1124 1130
92. G.D. Zeevalk, L.P. Bernard, D.S. Albers, O. Mirochnitchenko, W.J. Nicklas, and P.K. Sonsalla Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures J. Neurochem. 68 1997 426 429
93. G.D. Zeevalk, L. Manzino, J. Hoppe, and P. Sonsalla In vivo vulnerability of dopamine neurons to inhibition of energy metabolism Eur. J. Pharmacol. 320 1997 111 119
94. G.D. Zeevalk, L.P. Bernard, and W.J. Nicklas Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism J. Neurochem. 70 1998 1421 1430
95. G.D. Zeevalk, L. Manzino, and P.K. Sonsalla NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum Exp. Neurol. 161 2000 638 646